Caxton Associates LP Agios Pharmaceuticals, Inc. Transaction History
Caxton Associates LP
- $1.78 Billion
- Q1 2024
A detailed history of Caxton Associates LP transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Caxton Associates LP holds 37,189 shares of AGIO stock, worth $1.6 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
37,189Holding current value
$1.6 Million% of portfolio
0.06%Shares
4 transactions
Others Institutions Holding AGIO
# of Institutions
207Shares Held
60MCall Options Held
365KPut Options Held
457K-
Farallon Capital Management LLC San Francisco, CA5.59MShares$241 Million0.76% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.57MShares$240 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.66MShares$201 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V84.01MShares$173 Million1.84% of portfolio
-
State Street Corp Boston, MA3.14MShares$135 Million0.0% of portfolio
About AGIOS PHARMACEUTICALS, INC.
- Ticker AGIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,818,000
- Market Cap $2.36B
- Description
- Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...